XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Registered Direct Offering
Private Placement
Common Stock
Common Stock
Registered Direct Offering
Common Stock
Private Placement
Additional paid in capital
Additional paid in capital
Registered Direct Offering
Additional paid in capital
Private Placement
Treasury stock
Accumulated deficit
Beginning balance, common shares (in shares) at Dec. 31, 2021       135,566,227              
Beginning balance at Dec. 31, 2021 $ 122,368     $ 14     $ 253,744     $ 0 $ (131,390)
Ending balance, common shares (in shares) at Mar. 31, 2022       125,613,424              
Ending balance at Mar. 31, 2022 50,051     $ 14     257,602     (57,350) (150,215)
Beginning balance, common shares (in shares) at Dec. 31, 2021       135,566,227              
Beginning balance at Dec. 31, 2021 122,368     $ 14     253,744     $ 0 (131,390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (75,669)                   (75,669)
Equity-based compensation expense 8,938           8,938        
Repurchase of shares as a result of Forward Share Purchase Agreements (in shares)       (9,952,803)           (9,952,803)  
Repurchase of shares as a result of Forward Share Purchase Agreements (57,350)                 $ (57,350)  
Issuance of common stock as consideration for the acquisition of ProModel Corporation (in shares)       649,976              
Issuance of common stock as consideration for the acquisition of ProModel Corporation 7,501           7,501        
Exercise of warrants (in shares)       51              
Exercise of warrants 1           1        
Ending balance, common shares (in shares) at Jun. 30, 2022       126,263,451              
Ending balance at Jun. 30, 2022 5,789     $ 14     270,184     (57,350) (207,059)
Beginning balance, common shares (in shares) at Mar. 31, 2022       125,613,424              
Beginning balance at Mar. 31, 2022 50,051     $ 14     257,602     (57,350) (150,215)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (56,844)                   (56,844)
Equity-based compensation expense 5,080           5,080        
Issuance of common stock as consideration for the acquisition of ProModel Corporation (in shares)       649,976              
Issuance of common stock as consideration for the acquisition of ProModel Corporation 7,501           7,501        
Exercise of warrants (in shares)       51              
Exercise of warrants 1           1        
Ending balance, common shares (in shares) at Jun. 30, 2022       126,263,451              
Ending balance at Jun. 30, 2022 $ 5,789     $ 14     270,184     (57,350) (207,059)
Beginning balance, common shares (in shares) at Dec. 31, 2022 127,022,363     127,022,363              
Beginning balance at Dec. 31, 2022 $ (37,872)     $ 14     272,528     (57,350) (253,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (43,109)                   (43,109)
Equity-based compensation expense 7,799           7,799        
Issuance of Private Placement shares (in shares)         11,848,341 13,888,889          
Issuance of Private Placement shares   $ 6,765 $ 7,081   $ 1 $ 2   $ 6,764 $ 7,079    
Issuance of shares for equity-based compensation awards, net (in shares)       1,984,523              
Issuance of shares for equity-based compensation awards, net $ (2,237)           (2,237)        
Issuance of shares for exercised convertible notes (in shares)       188              
Issuance of shares purchased under ESPP (in shares)       708,470              
Ending balance, common shares (in shares) at Jun. 30, 2023 155,452,774     155,452,774              
Ending balance at Jun. 30, 2023 $ (61,573)     $ 17     291,933     (57,350) (296,173)
Beginning balance, common shares (in shares) at Mar. 31, 2023       141,823,207              
Beginning balance at Mar. 31, 2023 (54,039)     $ 16     282,573     (57,350) (279,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (16,895)                   (16,895)
Equity-based compensation expense 3,994           3,994        
Issuance of Private Placement shares (in shares)         11,848,341            
Issuance of Private Placement shares   $ 6,765     $ 1     $ 6,764      
Issuance of shares for equity-based compensation awards, net (in shares)       1,072,662              
Issuance of shares for equity-based compensation awards, net $ (1,398)           (1,398)        
Issuance of shares for exercised convertible notes (in shares)       94              
Issuance of shares purchased under ESPP (in shares)       708,470              
Ending balance, common shares (in shares) at Jun. 30, 2023 155,452,774     155,452,774              
Ending balance at Jun. 30, 2023 $ (61,573)     $ 17     $ 291,933     $ (57,350) $ (296,173)